API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
http://investors.rexahn.com/news-releases/news-release-details/rexahn-pharmaceuticals-present-two-upcoming-conferences
http://investors.rexahn.com/news-releases/news-release-details/rexahn-pharmaceuticals-announces-collaboration-zhejiang-haichang
http://investors.rexahn.com/news-releases/news-release-details/rexahn-pharmaceuticals-receives-notice-allowance-new-us-patent-0
http://investors.rexahn.com/news-releases/news-release-details/rexahn-pharmaceuticals-presents-new-preclinical-data-supinoxintm
http://investors.rexahn.com/news-releases/news-release-details/rexahn-announces-8-million-registered-direct-offering
http://investors.rexahn.com/news-releases/news-release-details/rexahn-pharmaceuticals-receives-new-us-patent-supinoxintm